Literature DB >> 3366177

The protective effect of Meciadanol (O-methyl-3(+)-catechin) on experimental ulceration.

A P Jayaraj1, M R Lewin, F I Tovey, M E Kitler, C G Clark.   

Abstract

Meciadanol, (O-methyl-3(+)-catechin), a histidine decarboxylase inhibitor was shown to have a marked protective action against experimental peptic ulceration in three rat models. The three methods used to induce ulceration were the instillation of absolute alcohol, pyloric ligation following an ulcerogenic South Indian diet and the instillation of rice bran oil into the stomach after pyloric ligation. Meciadanol was shown to reduce incidence, numbers and areas of ulceration and protected mast cells against degranulation and to preserve a normal vascular patterns. Furthermore, Meciadanol reduced gastric acid output and concentration in the pylorus ligation model. These results indicate that Meciadanol may be useful for the treatment of peptic ulcers in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366177     DOI: 10.1016/0014-2999(88)90785-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  (-)-epigallocatechin gallate inhibits the pacemaker activity of interstitial cells of cajal of mouse small intestine.

Authors:  Kweon Young Kim; Soo Jin Choi; Hyuk Jin Jang; Dong Chuan Zuo; Pawan Kumar Shahi; Shankar Prasad Parajuli; Cheol Ho Yeum; Pyung Jin Yoon; Seok Choi; Jae Yeoul Jun
Journal:  Korean J Physiol Pharmacol       Date:  2008-06-30       Impact factor: 2.016

2.  The effect of epigallocatechin gallate on intestinal motility in mice.

Authors:  Michal Ceregrzyn; Atsukazu Kuwahara
Journal:  Environ Health Prev Med       Date:  2003-05       Impact factor: 3.674

Review 3.  Preventative and Therapeutic Potential of Flavonoids in Peptic Ulcers.

Authors:  Wenji Zhang; Yingyi Lian; Qiuhua Li; Lingli Sun; Ruohong Chen; Xingfei Lai; Zhaoxiang Lai; Erdong Yuan; Shili Sun
Journal:  Molecules       Date:  2020-10-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.